European Mistletoe (Viscum album): Benefits, Dosage, Safety & Evidence

Frequently asked questions

How does European mistletoe work in cancer treatment?

European mistletoe contains viscotoxins and lectins (ML-I, ML-II) that stimulate immune activity and may induce apoptosis in cancer cells. These compounds activate natural killer cells and enhance immune surveillance. In European integrative oncology, injectable extracts like Iscador are used alongside conventional treatments to improve quality of life, reduce chemotherapy side effects, and potentially slow tumor progression. Evidence Level: C. Research shows promising but mixed results, particularly for symptom management and immune support.

Does European mistletoe interact with medications?

Yes, European mistletoe has clinically significant interactions with immunosuppressant medications. Because mistletoe stimulates immune function, it can counteract drugs prescribed after organ transplants or for autoimmune conditions. Concurrent use with immunosuppressive therapy is contraindicated. Patients on antihypertensive or antidiabetic medications should also exercise caution, as mistletoe may affect blood pressure and glucose levels. Evidence Level: C. Always inform your healthcare provider about all herbal supplements.

What is the recommended dosage for European mistletoe?

Dosage depends on the preparation and purpose. Injectable extracts like Iscador require professional medical supervision and are administered in clinical settings, typically 2-3 times weekly. For traditional tea preparations, 2-4 grams of dried leaves daily is commonly recommended. Self-treatment for serious conditions is not advised. Evidence Level: Traditional. A qualified healthcare practitioner should determine appropriate dosing based on individual health status and treatment goals.

Is European mistletoe safe during pregnancy and breastfeeding?

European mistletoe is considered unsafe during pregnancy and breastfeeding. The plant contains compounds that may stimulate uterine contractions, potentially increasing miscarriage risk. Active constituents can pass into breast milk, posing risks to nursing infants. Historical use included mistletoe for fertility support, but modern guidance strongly contraindicates its use during pregnancy. Evidence Level: C. Women who are pregnant, nursing, or trying to conceive should avoid all mistletoe preparations.

What conditions is European mistletoe used to treat?

European mistletoe has been used traditionally for hypertension, epilepsy, and fertility support. In modern integrative medicine, it is primarily researched and applied in oncology settings as an adjunctive therapy. Injectable extracts are used to support cancer patients by improving quality of life, reducing fatigue, and mitigating chemotherapy side effects. Evidence Level: C. While historical applications are well-documented, current evidence is strongest for integrative oncology use under professional supervision.

PubMed-compiled information sheet

This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.

Compiled from 29 PubMed articles · model: gemma4:31b

Summary

European mistletoe (Viscum album) is a hemiparasitic plant used primarily as an adjuvant therapy in oncology to improve quality of life and exert immunomodulatory effects [PMID:35325897, PMID:32211937].

Background

Viscum album is an evergreen woody hemiparasitic shrub found in Europe, Northern Africa, and Southern Asia [PMID:35998245, PMID:38666019]. It is characterized by a unique life cycle, an extremely large genome, and an unusual mode of cellular respiration lacking mitochondrial complex I [PMID:34713513, PMID:37484460].

Traditional uses

Historically, it was considered a panacea and used to treat headaches and seizures [PMID:35998245]. It has also been used in the treatment and prophylaxis of cardiovascular diseases [PMID:38666019].

Active compounds

Key bioactive constituents include lectins (such as ML-1), viscotoxins, flavonoids, phenolic acids, phenylpropanoids, triterpenes, alkaloids, and polysaccharides [PMID:38234984, PMID:25813519, PMID:32211937, PMID:39128961].

Mechanism of action

The plant exerts anti-proliferative, pro-apoptotic, and cytotoxic effects on cancer cells [PMID:38234984, PMID:32211937]. It functions as an immunomodulator, stimulating natural killer (NK) cells and inducing the expansion of Vγ9Vδ2 T cells [PMID:20484913, PMID:32604868]. Additionally, lectin ML-1 may trigger the release of endorphins to improve patient well-being [PMID:38234984].

Clinical evidence

Evidence ACancer (General/Adjuvant)

Meta-analyses attribute life-prolonging and health-related quality of life (HRQL) improving properties to additive therapy [PMID:35325897].

Evidence CCancer (General/Adjuvant)

Used to reduce disease- and treatment-related symptoms and improve quality of life [PMID:35325897, PMID:16450726].

Evidence DCardiovascular Disease

Data from in vitro and animal models suggest promising cardioprotective properties and effects on blood pressure [PMID:38666019].

Evidence DCanine High-Grade Astrocytoma

In vitro evidence shows cytotoxicity to canine cells and additive effects when combined with mebendazole [PMID:35051115].

Safety & adverse effects

Viscum album can be toxic in high doses, but conventional doses have not been convincingly shown to cause clinically apparent liver injury [PMID:35998245]. It is generally reported to have a low toxicity profile [PMID:8493669].

Dosage & administration

Commonly administered as subcutaneous or intra-tumoral injections of aqueous extracts [PMID:34244531, PMID:16450726]. No PubMed data available. Consult a healthcare provider.

Evidence summary

Evidence is strongest for its use as an adjuvant in cancer care (Meta-analyses/Reviews), though some clinical trials are noted to have poor methodological design. Other claims (cardioprotective, antimicrobial) are based on preclinical or in vitro data.

PubMed sources

1.PMID: 35998245 (2012) — The Anti-Inflammatory Activity of Viscum album. · CITED REFERENCE
2.PMID: 38234984 (2023) — Viscum album (mistletoe) extract for dogs with cancer? · Frontiers in veterinary science
3.PMID: 34713513 (2022) — The gene space of European mistletoe (Viscum album). · The Plant journal : for cell and molecular biology
4.PMID: 37484460 (2023) — The Viscum album Gene Space database. · Frontiers in plant science
5.PMID: 37514321 (2023) — The Antioxidant Activity of Mistletoes (Viscum album and Other Species). · Plants (Basel, Switzerland)
6.PMID: 37622692

European Mistletoe

Sources & Citations

Calculate a safe dose of European Mistletoe

Evodia Rutaecarpa

Caragana sinica

Jatropha gossypiifolia

Frequently asked questions

Summary

Background

Traditional uses

Active compounds

Mechanism of action

Clinical evidence

Safety & adverse effects

Dosage & administration

Evidence summary

PubMed sources

Government sources

European Mistletoe

Sources & Citations

Calculate a safe dose of European Mistletoe

Related Herbs

Evodia Rutaecarpa

Caragana sinica

Jatropha gossypiifolia

Frequently asked questions

Summary

Background

Traditional uses

Active compounds

Mechanism of action

Clinical evidence

Safety & adverse effects

Dosage & administration

Evidence summary

PubMed sources

Government sources